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AbstrAct
The rapidly expanding field of mobile health (mHealth) seeks to harness increasingly affordable and ubiquitous mobile digital technologies including 
smartphones, tablets, apps and wearable devices to enhance clinical care. Accumulating evidence suggests that mHealth interventions are 
increasingly being adopted and valued by people living with serious mental illnesses such as schizophrenia and bipolar disorder, as a means of better 
understanding and managing their condition. We draw on experiences from three geographically and methodologically distinct mHealth studies to 
provide a pragmatic overview of the key challenges and considerations relating to the process of developing digital interventions for this population. 
The Promise and challenges of mobile 
healTh (mhealTh) in PsychiaTry
The opportunities presented by digital technologies including smart-
phones, apps and wearable devices for delivering new paradigms of 
care in people experiencing serious mental illness (SMI) have stimu-
lated a surge of interest.1
The portable, connected nature of such devices enables the longi-
tudinal, remote and high-resolution capture of clinical variables in 
ecologically valid settings—both actively, for example, via self-rated 
assessments, and passively, using sensors to sample objective markers 
of social, emotional and cognitive states, with low user burden. Informa-
tion can be fed back to the patient and their clinical teams in real time, 
offering the opportunity to facilitate self-management, and trigger timely, 
preventative interventions. Mobile platforms may promote communica-
tion between patients and clinicians, and allow the delivery of therapies 
tailored to each user’s clinical status. The increasing ubiquity, affordability 
and ownership of digital technologies,2 including in populations with 
SMI3–5 has the potential to address the disparities in healthcare provi-
sion in underserved populations with SMI globally, including members 
of ethnic minorities, low-income groups, and individuals living in rural 
and low-resource settings.6 Several lines of evidence now indicate that 
people experiencing SMI already use,3 5 or are interested in using,7 mobile 
devices and web-based technology to manage their conditions, and that 
these are acceptable across a range of age, sex, educational level and 
clinical characteristics.8
As the field proliferates and establishes itself as a discipline in its 
own right, unique challenges emerge.9 10 A rush to implementation, with 
insufficient attention to design and usability during development, may be 
detrimental to the longer-term adoption of an intervention by patients 
and clinicians. Most interventions have been tested in small studies that 
report short-term feasibility and acceptability, largely with positive find-
ings,11 12 raising questions around their performance over longer dura-
tions, in more heterogeneous patient groups. Evidence gathered through 
rigorous evaluation frameworks13–15 will be required to ensure purported 
benefits are realised, and that these outweigh potential harms such as 
breaches of security and privacy,16 devices and data that are of inade-
quate quality for the clinical application, and erosion of the therapeutic 
relationship.17
In this context, how do we optimise the process of designing effec-
tive digital solutions in a timely, cost-effective manner? Which clinical 
dimensions do we target? How do we create interventions that adapt to 
a shifting technological landscape, while retaining their core functionality? 
And how, when and to what extent do we integrate end users in the 
design process? Here, we explore these key considerations by drawing on 
the experiences gained from three methodologically and geographically 
diverse mHealth studies in people experiencing SMI (table 1), and offer a 
pragmatic and critical overview relating to the process of designing digital 
interventions for this population.
defining The inTervenTion
As the field gains legitimacy and attracts funding, there is a risk that 
technology is deployed for the sake of implementing technology alone, 
rather than being applied to target specific clinical problems. Clini-
cian-researchers are however in a unique position to guide develop-
ment of interventions by learning from patients, identifying areas of 
unmet clinical need, and then considering which of the various proper-
ties of mobile technologies might address these. The Sleepsight study 
(NM, London, UK, in submission) grew from the observation that sleep 
and circadian rhythm disturbance is a common but often neglected 
clinical complaint accompanying relapse in schizophrenia, and used 
the remote, passive, high-frequency, real time qualities of mobile 
and consumer wearable technologies to capture this dimension. The 
SIMPLe study18 19(DH-M, Barcelona, Spain), responded to the need to 
widen the reach and cost-effectiveness of psychoeducation in bipolar 
disorder, by building a bidirectional smartphone platform for gathering 
user-rated symptoms, and delivering personalised preventative psycho-
education in real time. The CLIMB study 20 (BB, San Francisco, USA) 
identified a need for new treatments to remediate impairments in social 
cognition and social functioning in psychosis-spectrum disorders—an 
underaddressed clinical dimension in this population—by harnessing 
properties inherent to digital technologies: remote interactive video 
communication, real time group messaging, and engaging cognitive 
training exercises delivered via a tablet device.
At this early stage, we suggest that a specific clinical dimension or 
unmet need should drive the research question; once the parameters and 
key variables are delineated, the development of a digital solution that 
addresses the area of need can begin. As the field progresses, individual 
tools can be amalgamated into multidimensional, modular and more flex-
ible platforms.
develoPing ParTnershiPs
Establishing interdisciplinary collaborations that harness the expertise 
of clinicians, patients, data scientists, software engineers and user 
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Table 1 Summary of characteristics of the three mHealth studies.
sleepsight simPle climb
Disorder Schizophrenia. Bipolar disorder I and II. Chronic psychotic disorders: schizophrenia, 
schizoaffective disorder, bipolar disorder 
with psychosis.
Target clinical dimension(s) Rest-activity patterns, and their relation to 
symptomatic deterioration and relapse.
Self-reported positive and negative affect; 
relapse.
Social cognition and functioning.
Technologies 1) Consumer wearable device with 
accelerometer and heart rate sensor; 
2) Android smartphone provided by 
research team; 3) Custom designed 
smartphone application with self-rated 
symptom severity items, which also 
accessed smartphone sensors including 
accelerometer and smartphone usage 
meta-data.
1) Participant’s own Android 
smartphone; 2) Custom designed 
smartphone application with self-rated 
symptom severity items, and tailored 
psychoeducational messages.
1) iPad provided by research team; 2) 
Commercially available computerised social 
cognition training app; 3) Commercially 
available videoconferencing and social 
networking app.
Approach to development Iterative focus groups informing app design 
and selection of mobile devices.
User-centred design, with iterative user 
involvement over the course of the study 
using online surveys, individual interviews 
and focus groups (figure 1).
Theory-driven intervention design, 
integrating structured training of social 
cognitive abilities with weekly group 
teletherapy with group texting. Online 
surveys that assess current social 
difficulties and patient-centred goals are 
administered to customise the group 
teletherapy sessions.
Project partners academic:
Clinicians and bioinformaticians from King’s 
College London; app developers from 
Northwestern University, USA.
non-academic:
Data access agreement with Fitbit.
academic:
Clinicians from the University of Barcelona, 
Spain, and collaborating academic centre in 
Santiago, Chile.
non-academic:
App development was outsourced to a 
commercial entity in Paraguay.
academic:
Clinicians and data scientists at University 
of California at San Francisco.
non-academic:
Posit science;
Business associate agreement with 
Google.
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experience designers are critical in ensuring that an intervention meets 
scientific and technical standards. For example, the implementation of 
CLIMB (San Francisco, USA) relied on (1) an academic infrastructure 
that supported the incubation, development and evaluation of digital 
health technologies in clinical settings; (2) a long-standing collaboration 
between the academic research group and Posit Science, a neurotech-
nology company that provided customised software free of charge; (3) 
a business associate agreement with Google, which enabled the free 
use and integration of secure peer-to-peer communication technology; 
and (4) the geographical proximity of these entities, which accelerated 
development and deployment of the intervention.
However, traditions of scientific independence, difficulties in sharing 
implicit knowledge and organisational barriers can form obstacles to 
collaboration. Employing ‘team science’ principles21—scheduling meet-
ings and initiatives to promote interdisciplinary dialogue, and ultimately 
the formation of a collective knowledge base—can help to align objec-
tives and nurture effective collaborations. Before any work begins, it is 
essential that agreement is reached between collaborators on issues 
of payment, academic credit, authorship, intellectual property, and data 
ownership, storage and security. Another critical issue which can be 
detrimental for a project is if a partner withdraws support, as was the 
case in the SIMPLe project. Where possible, signing a partnership agree-
ment may mitigate this risk, together with contingency planning in case 
of this eventuality.
Although CLIMB benefited from the unusually technology-rich envi-
ronment of San Francisco, digital interventions can be developed in 
tech hubs and rapidly disseminated worldwide, including to low-income 
and middle-income countries6 and areas of conflict or disaster.22 Effective 
collaborations can also be formed internationally: in addition to partners in 
the main academic institution in London, the Sleepsight team benefited 
from working with developers from Northwestern University, Chicago, 
USA with expertise in mHealth app development. While we realise that 
not all digital health projects require this infrastructure to be successful, 
we believe that fostering trusted, multidisciplinary networks greatly 
enhances the development process.
involving PaTienTs
mHealth interventions are likely to be adopted for long-term use only if 
they provide intrinsic value for the user in managing their condition, or 
improve critical aspects of their functioning and well-being. Involving 
end-users in the co-development of digital interventions has therefore 
become axiomatic to this goal, however, it is not yet clear how this is 
best implemented, and only a limited number of studies to date have 
reported user-involvement.23
Truly user-centred design (UCD) involves a bottom-up approach, where 
users are integral to forming the research agenda, clinical focus and tech-
nology selection over the entirety of the development cycle. From the 
project’s infancy, SIMPLe employed online surveys, focus groups and 
individual interviews in an iterative fashion, to gather opinion, implement 
prototypes, then evaluate, refine and re-evaluate these (figure 1). A 
setback in the process was not considered a failure, but an opportunity 
to optimise long-term acceptability. UCD is likely to have contributed to 
the high adherence rate of 74% over the 3-month study, however it was 
intensive of the project’s time, and financial and human resources,19 and 
added significant complexity to the process. Several features were devel-
oped and tested, but discarded from the final version of the app.
Sleepsight and CLIMB also found encouraging adherence rates of over 
80%, but involved a more top-down approach, where patients and public 
were consulted through user groups on aspects of the design once an 
overarching approach had been formulated by the research team. This 
suggests that a more conservative approach to patient involvement 
also resulted in acceptable interventions, and that the optimal balance 
between bottom-up and top-down approaches remains unclear. In both 
cases, user groups tended to be composed of motivated ‘patient-cham-
pions’ who may not be representative of the wider patient population.
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figure 1 User-centred development pathway for the SIMPLe study.
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naTive or exisTing sofTware PlaTforms?
Do we build native software platforms (SIMPLe and Sleepsight), or 
leverage existing technology and repurpose it to meet the needs of the 
project (CLIMB)?
While building native software requires up-front expenditures of time, 
energy and capital, it also allows for specific difficulties of people with 
SMI to be taken into account, including cognitive impairments, poor tech-
nology literacy and text reading level.24 This is a critical aspect, as the 
potential of digital interventions is known to be mitigated by design and 
usability issues: incorporating the principles of navigational simplicity, 
text reading ease and comprehensibility into the development of native 
technology for SMI was shown to increase the acceptability of the inter-
vention.24 There are, nonetheless, potential risks associated with building 
native technology for SMI. For example, technological advances may 
make the prototype for the intervention already obsolete and uncom-
petitive by the time the development process is complete, with obvious 
implications on the acceptability and scalability of the intervention. One 
strategy for overcoming this limitation is to outsource design and devel-
opment to established firms, so that the intervention is regularly main-
tained and enhanced, however this usually requires additional costs that 
may be unaffordable to early stage researchers.
An alternative is to capitalise on existing solutions that are in general 
use, provided they meet the specific needs and goals of the study, are 
secure, and compliant with ethical and clinical governance structures. 
Advantages include a significant reduction in costs and the possibility 
to promptly test the feasibility and acceptability of the technology in the 
clinical population. However, researchers have very little control over the 
development process, and may need to adapt the intervention to the 
rapidly changing features of the digital tool, in turn creating problems 
with consistency of study procedures and replicability of findings.
In both scenarios, allowing interoperability between mobile operating 
systems is desirable, particularly android and iOS systems, in order to 
maximise the reach and generalisability of the intervention. Both CLIMB 
and SIMPLe employed software that could be freely downloaded to any 
smartphone, and other studies have used cost-effective approaches 
such as text message rating of mood,25 the utility of which has also been 
demonstrated in low-income and middle-income settings.26
consumer or clinical grade devices?
A key objective for the field is developing interventions which are 
affordable and acceptable for extended use. For studies such as Sleep-
sight, which capture passive behavioural and physiological variables 
from accelerometer, light and GPS sensors, validated ‘clinical grade’ 
wearable and smartphone devices which meet these criteria are not 
currently available. Similarly, developing bespoke devices is a prohib-
itively lengthy and expensive process. Sleepsight, like several related 
studies,27 28 therefore harnessed lower-cost consumer technologies, 
which capitalises on the functionality, user experience research that 
has been invested in their development. However, these devices 
are not validated in clinical populations, and in the case of wearable 
devices, data are preprocessed on the device using unpublished algo-
rithms, to which the research team do not have access. This raises 
questions around their validation, data quality, replicability and scientific 
acceptability.
We suggest that consumer devices have a useful role, as long as we 
are conscious of their limitations. First, the technology needs to be ‘good 
enough’ to address the clinical question. For Sleepsight, consumer wear-
able devices are likely to be adequate for estimation of gross rest-ac-
tivity patterns, and detecting variability in this signal against background 
noise. However, they are unable to provide raw accelerometer data that 
permit reliable estimation of sleep, analysis of variability in motor activity 
on shorter timescales, or beat-to-beat variability in heart rate. Second, 
we attempted to minimise variability between devices by providing all 
participants with standardised study devices, and by primarily examining 
longitudinal within-person variation. Third, given the rapid development 
cycle of consumer devices, the platform was designed to integrate with 
new devices as they emerge, thus ‘future-proofing’ the intervention.
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As the technological landscape rapidly evolves, new opportunities will 
arise for delivering digital tools for mental health. Closer collaboration 
between academic and industry partners will be necessary in fusing the 
advantages of consumer and clinical grade technologies in the develop-
ment of devices that integrate seamlessly into the user’s everyday life, 
while delivering clinical-quality data.
conclusions
In attending to the many challenges facing the field—ensuring privacy 
and security,16 understanding new types of data,29 integrating mHealth 
into existing clinical infrastructure and transitioning from studies of 
feasibility to those of effectiveness—the importance of the underlying 
process of developing digital tools should not be overlooked. Each point 
discussed above relates ultimately to the production of digital interven-
tions that are valued by patients and clinicians, and therefore compat-
ible with long-term use, while meeting clinical and scientific standards.
The successful development of a digital intervention for people expe-
riencing SMI requires the coordinated activity of clinical researchers 
with patients, clinicians and the technology sector. The intervention 
should emerge in response to a symptom dimension or unmet clinical 
need, which resonates with the patient group it is intended to serve. 
The native development of a device or software-based intervention is an 
expensive and laborious process that can limit the quality, life span and 
breadth of the product, with important implications on its acceptability 
and scalability. Therefore, building strategic and appropriately formalised 
academic-industry partnerships is a viable alternative that can result in 
customised digital tools that are more easily adopted and disseminated.
Finally, the flow of knowledge and technology between stakeholders 
in academia and industry, for example, by sharing code via open-source 
frameworks, will be critical to success. Adapting, testing and improving 
interventions in different settings globally will enhance transparency, 
replicability, efficiency and pace of development for this exciting field.
Contributors All authors contributed equally to the manuscript.
funding NM is supported by a Medical Research Council Clinical Research Training 
Fellowship,MR/P001378/1. BB is supported by the National Institute of Mental Health 
Training Grant T32 and partially by Posit Science, a company with a commercial 
interest in the training software used in the CLIMB study. SIMPLe was supported 
by research grants from the Spanish Ministry of Economy and Competitiveness 
PI14/00286 and PI15/00588, Instituto de Salud Carlos III. DH-M is supported by a Rio 
Hortega grant (CM15/00127) from Instituto de Salud Carlos III.
competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
doi:10.1136/eb-2017-102765
Received 15 June 2017; Revised 10 September 2017; Accepted 13 September 2017
references
 1 hollis c, Morriss R, Martin J, et al. Technological innovations in mental healthcare: 
harnessing the digital revolution. Br J Psychiatry 2015;206:263–5.
 2 Poushter J. Pew Research Centre. Smartphone ownership and internet usage 
continues to climb in emerging economies. 2016.
 3 firth J, Cotter J, Torous J, et al. Mobile phone ownership and endorsement of “ 
mHealth ” among people with psychosis: a meta-analysis of cross-sectional Studies. 
Schizophr Bull 2016;42.
 4 robotham d, Satkunanathan S, Doughty L, et al. Do we still have a digital divide in 
mental health? a five-year survey follow-up. J Med Internet Res 2016;18:e309.
 5 gay K, Torous J, Joseph A, et al. Digital technology use among individuals with 
schizophrenia: results of an online survey. JMIR Ment Health 2016;3:e15.
 6 naslund Ja, Aschbrenner KA, Araya R, et al. Digital technology for treating and 
preventing mental disorders in low-income and middle-income countries: a narrative 
review of the literature. Lancet Psychiatry 2017;4:486–500.
 7 lal s, Dell'Elce J, Tucci N, et al. Preferences of young adults with first-episode 
psychosis for receiving specialized mental health services using technology: a survey 
study. JMIR Ment Health 2015;2:e18.
 8 berry n, Lobban F, Emsley R, et al. Acceptability of Interventions delivered online and 
through mobile phones for people who experience severe mental health problems: a 
systematic review. J Med Internet Res 2016;18:e121.
 9 Torous J, Keshavan M, Gutheil T. Promise and perils of digital psychiatry. Asian J 
Psychiatr 2014;10:120–2.
 10 national institute of mental health. Technology and the future of mental health 
treatment. 2017 https://www. nimh. nih. gov/ health/ topics/ technology- and- the- future- 
of- mental- health- treatment/ index. shtmlhttp:// www. webcitation. org/ 6st8rIvDO 
(accessed 21 Aug 2017).
 11 naslund Ja, Marsch LA, McHugo GJ, et al. Emerging mHealth and eHealth 
interventions for serious mental illness: a review of the literature. J Ment Health 
2015;24:321–32.
 12 firth J, Torous J. Smartphone apps for schizophrenia: a systematic review. JMIR 
Mhealth Uhealth 2015;3:e102.
 13 lewis Tl, Wyatt JC. mHealth and mobile medical apps: a framework to assess risk 
and promote safer use. J Med Internet Res 2014;16:e210.
 14 chan s, Torous J, Hinton L, et al. Towards a framework for evaluating mobile mental 
health apps. Telemed J E Health 2015;21:1038–41.
 15 Torous Jb, Chan SR, Yellowlees PM, et al. To use or not? evaluating aspects of 
smartphone apps and mobile technology for clinical care in psychiatry. J Clin Psychiatry 
2016;77:e734–e738.
 16 Torous J, Roberts LW. Needed innovation in digital health and smartphone 
applications for mental health: transparency and trust. JAMA Psychiatry 
2017;74:437–8.
 17 greist rl, Greist JH. The therapeutic aliance in the age of digital health, 2017. http:// 
digitalageblog. psychiatrist. com/ 2016/ 05/ the- therapeutic- alliance- in- age- of. html (21 
Aug 2017).
 18 hidalgo-mazzei d, Mateu A, Reinares M, et al. Self-monitoring and psychoeducation 
in bipolar patients with a smart-phone application (SIMPLe) project: design, 
development and studies protocols. BMC Psychiatry 2015;15:52.
 19 hidalgo-mazzei d, Mateu A, Reinares M, et al. Psychoeducation in bipolar disorder 
with a SIMPLe smartphone application: feasibility, acceptability and satisfaction. J 
Affect Disord 2016;200:58–66.
 20 biagianti b, Schlosser D, Nahum M, et al. Creating Live Interactions to Mitigate 
Barriers (CLIMB): a mobile iIntervention to improve social functioning in people with 
chronic psychotic dDisorders. JMIR Ment Health 2016;3:e52.
 21 börner K, Contractor N, Falk-Krzesinski HJ, et al. A multi-level systems perspective 
for the science of team science. Sci Transl Med 2010;2:49cm24.
 22 ruzek Ji, Kuhn E, Jaworski BK, et al. Mobile mental health interventions following 
war and disaster. Mhealth 2016;2:37.
 23 Killikelly c, He Z, Reeder C, et al. Improving Adherence to Web-Based and Mobile 
Technologies for People With Psychosis: Systematic Review of New Potential 
Predictors of Adherence. JMIR Mhealth Uhealth 2017;5:e94.
 24 rotondi aJ, Eack SM, Hanusa BH, et al. Critical design elements of e-health 
applications for users with severe mental illness: singular focus, simple architecture, 
prominent contents, explicit navigation, and inclusive hyperlinks. Schizophr Bull 
2015;41:440–8.
 25 bopp Jm, Miklowitz DJ, Goodwin GM, et al. The longitudinal course of bipolar 
disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord 
2010;12:327–34.
 26 chandra Ps, Sowmya HR, Mehrotra S, et al. ‘SMS’ for mental health—feasibility 
and acceptability of using text messages for mental health promotion among young 
women from urban low income settings in India. Asian J Psychiatr 2014;11:59–64.
 27 Torous J, Kiang MV, Lorme J, et al. New tools for new research in psychiatry: a 
scalable and customizable platform to empower data driven smartphone research. 
JMIR Ment Health 2016;3:e16.
 28 naslund Ja, Aschbrenner KA, Bartels SJ. Wearable devices and smartphones for 
activity tracking among people with serious mental illness. Ment Health Phys Act 
2016;10:10–17.
 29 Torous J, Staples P, Onnela JP. Realizing the potential of mobile mental health: new 
methods for new data in psychiatry. Curr Psychiatry Rep 2015;17:602.
group.bmj.com on October 17, 2017 - Published by http://ebmh.bmj.com/Downloaded from 
perspectives from three mHealth studies
living with serious mental illness: 
Developing digital interventions for people
Bruno Biagianti, Diego Hidalgo-Mazzei and Nicholas Meyer
 published online October 12, 2017Evid Based Mental Health 
 http://ebmh.bmj.com/content/early/2017/10/12/eb-2017-102765
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://ebmh.bmj.com/content/early/2017/10/12/eb-2017-102765
This article cites 25 articles, 2 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (13)Open access
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on October 17, 2017 - Published by http://ebmh.bmj.com/Downloaded from 
